HIMS
Hims & Hers Health, Inc.
stock NYSE

$HIMS lässt grüßen.

Believe it or not, calls on HIMS

Give me a reason I shouldn’t yolo 100k into $HIMS Tuesday open

I think buying $20 calls on $HIMS will be the true money maker. Extremely oversold

Wouldn’t recommend ETH with the creator constantly selling his coin and most ETH based servers are moving towards Solano. SRFM has major backings and is worth a gamble (but it’s a gamble), HIMS is a considerable mention when looking at the health sector but the current lawsuit may cause their stock to keep dropping. I believe XLF is an etf but not sure what it covers and maybe considering allocating funds towards VOO if you’re looking for a stable ETF. Palantir is going to continue to grow, as well as AMD/NVIDIA and I believe intel may have more growth with the backing of USA government. Honestly not bad, a bit risky but if you’re willing to take that risk, definitely keep growing your positions but focus more of your income into VOO

Man, I haven't thought about subscription services to invest besides streaming services. I think services like HIMS and others that are similar could be a great investment move for myself

HOOD, HIMS, NFLX, PLTR here. At least you can write off your loss on your taxes. These stocks made money in 2025 then decided to all take a giant dump closing the year and then the first 6 weeks of 2026 so I'm going to get a tax bill for profits that have all been vaporized

I just got my HIMS boner pills and the wife started an argument RIP

HIMS is what we refer to as 'a trade' rather than a long-term investment. It has made money for swing traders - but unless that's what you're looking at HIMS as then you should not buy shares.

Yeah LLY’s drug seems to be winning. But HIMS minted a lot of millionaires so markets might be irrational on this one too

I think $HIMS is an excellent value investment at this point bc price is so distressed, so much fear, so many terrible scenarios already baked into price now… and they can and will monetize in so many different ways, their user base continues to grow and they keep paving more roads to make money 💰

I told my loved one I lost all my money on HIMS

If you've followed the HIMS fiasco with FDA action, I think it's pretty obvious that the tech bros either don't know what they don't know or will play FAFO until it results in a lawsuit.
So they'll keep pushing the edges until it results in a lawsuit, it will result in a high profile lawsuit, and THEN everyone will become concerned about liability.

Best OTM with good return (doesn’t mean less risky) based on scan is ASTS, IREN, RKLB, HIMS, HOOD, and many more

HIMS belongs to WSB and not here, imo.

this kind of question is weird because 1) markets can support multiple ppl 2) you can say this about any FANG type company for any product, and yet...
but more seriously, there is something to be said for UX. AMZN pharma is like AMZN video: a nightmare to actually use. HIMS is very streamlined to use bc it's their only product. even though UX is easy to replicate, for various reasons it often isn't, and it leads to niche players printing money
that said, management's credibility is in serious question now. i would personally wait to see them post good profit #s without the GLP tailwind before i owned any HIMS

First off, EXCELLENT post. This took actual critical thinking and an understanding of the business beyond "HIMS did something shady/stupid with GLP-1's and is therefore worthless."
I was an investor that recently sold my shares. I got burned on excellent headline fundamentals and ignored too many red flags.
Even after getting burned on my position, I still think this company has a LOT going for it. They built a great brand that was synonymous with easy, customizable generic medication that you technically need a doctor for, but honestly shouldn't. Hair growth and sexual health is a great example of this, and they did such a fantastic job with the marketing and customer onboarding/prescription process that customers were happy to pay a fat premium for a customized mix of ingredients and to avoid the hassle of going through the American healthcare system.
The big problem is they got greedy. They saw the core business slowing down, and got desperate to walk in the grey zone and aggressively mass market rip-off GLP-1's in a very questionably legal way. Mix that with Andrew Dudum's antics on Twitter, their deliberately vague approach to disclosing individual segment performance on earnings calls, and then the spectacular blow up with Novo the first time and the even more embarrassing and legally harmful one more recently.
I still think a really skilled operator could right this ship, and Dudum might even eventually do it with enough time and willingness to pivot away from the stupid knock off GLP-1 business. Like a Zuckerberg situation after navigating through the Cambridge Analytica scandal. Or, a handoff like Kaelenick to khosrashawhi (probably butchered both those names) for Uber, although that won't happen due to the share structure.
To answer your question, as of right now, it's hard for me to assign numbers to the core business because of the opaque numbers and the feeling of dishonesty I get from management. If Dudum issued an apology for his actions, pivoted away from GLP-1's and more toward a general health platform with labs and screening, and started properly disclosing numbers for each segment, I'd probably be interested somewhere near half to two-thirds of today's price depending on how bad the core numbers are looking. Even without growth, 70% plus gross margins give a lot of optionality to raise margins, and it's still a subscription business at the end of the day.

I will be the newest long term investor of HIMS once these 16.5 CSP cover.
Need some of those 37% short float boys to bail me out with a little squeeze. 🥺

HIMS stock was already well over $20 on their existing business of ED and hair loss treatment before they started into the GLP1 compounding business stream. That (and rampant speculation!) catapulted them up into the $70s.
I’m expecting them to bounce back into the $20s with good results, albeit with the legal threat hanging over the company.
Has always been a company with excessive volatility - the CEO (Palestinian married to a Jew) made public comments supporting US students who were anti-genocide. These whipped the zionists into a frenzy and it’s been a fairground ride ever since.

HIMS as a value question: what is the core worth if GLP1 goes to near zero